Week 1 - Phase 1 Metabolism: Detailed Study of Esterases and Epoxide Hydrolases

Overview of Phase 1 Metabolism: Supplementary Enzymes

  • Phase 1 metabolism involves more than just the Cytochrome P450 (CYP450) system; it includes other critical enzymes such as Epoxide Hydrolase and Various Esterases.

  • These enzymes catalyze the addition of water (hydrolysis or hydration) to specific functional groups, such as esters, amides, and epoxides.

  • Key Goals of these enzymes in metabolism include:

    • Deactivation of active drug molecules.

    • Activation of prodrugs into their active forms.

    • Increasing the water solubility of compounds to facilitate renal elimination.

Human Carboxyl Esterases (HCE1 and HCE2)

  • Esterase enzymes are responsible for the hydrolysis of drugs containing ester and amide functional groups.

  • Genetic Basis: Human carboxyl esterases are primarily encoded by two genes:

    • CES1CES1 (encoding for HCE1).

    • CES2CES2 (encoding for HCE2).

  • Structural Characteristics: The human carboxyl esterase enzyme is a trimeric enzyme, meaning it consists of three associated amino acid chains.

  • Reaction Mechanism (Serine Esterase):

    • The active site contains a serine residue whose hydroxyl (OHOH) group is positioned to interact with the carbonyl group (C=OC=O) of the substrate.

    • A catalytic triad, involving a histidine residue, facilitates the reaction. The histidine deprotonates the serine, making the oxygen a strong nucleophile.

    • Step 1: The activated oxygen of serine attacks the carbonyl carbon of the ester, forming a tetrahedral intermediate.

    • Step 2: The alcohol component of the original ester is released, and the carboxylic acid portion remains covalently bonded to the enzyme as an ester.

    • Step 3: A molecule of water is activated by the histidine (intermolecular interaction) to become a good nucleophile.

    • Step 4: The water molecule attacks the enzyme-bound intermediate, hydrolyzing the bond and releasing the final carboxylic acid product.

    • Outcome: The ester is successfully split into an alcohol and a carboxylic acid (Ester+H2O→Alcohol+Carboxylic Acid\text{Ester} + H_2O \rightarrow \text{Alcohol} + \text{Carboxylic Acid}).

Kinetics and Thermodynamics of Ester Hydrolysis

  • Enzymes function by lowering the activation energy (EaE_{a}) of a chemical reaction.

  • Uncatalyzed Reaction Example: Hydrolyzing isopropyl acetate in plain water at room temperature might take several years or even decades because the activation energy is too high.

  • Reaction Equation: Isopropyl Acetate+H2O→Acetic Acid+Isopropanol\text{Isopropyl Acetate} + H_2O \rightarrow \text{Acetic Acid} + \text{Isopropanol}.

  • Chemical Catalysis in a Lab: To speed up this reaction, chemists use two methods:

    • Adding a catalyst (e.g., a few drops of H2SO4H_2SO_4 to provide hydronium ions, H3O+H_3O^+) to protonate the carbonyl and provide an alternative, lower-energy pathway.

    • Increasing the temperature (TT). For example, heating the reaction to 100oC100^\text{o}C (373.15 K373.15\,K) increases the number of molecules with enough energy to overcome the barrier.

  • Biological Catalysis: In the human body, temperature is constant (approx. 310.15 K310.15\,K), so carboxyl esterases lower the EaE_a significantly through hydrogen bonding and the catalytic triad, allowing the reaction to occur in minutes rather than decades.

  • Arrhenius Equation: The rate constant (kk) is defined by k=Ae−EaRTk = A e^{-\frac{E_a}{RT}}:

    • AA is the pre-exponential factor.

    • EaE_a is the activation energy in Joules.

    • RR is the gas constant.

    • TT is the temperature in Kelvin.

Case Studies: Esterase Metabolism of Specific Drugs

Aspirin (Acetylsalicylic Acid)

  • Aspirin is hydrolyzed by Human Carboxyl Esterase 2 (HCE2) into salicylic acid.

  • Mixed Clinical Outcome:

    • Activation: This reaction activates the anti-inflammatory activity of the molecule.

    • Deactivation: This reaction deactivates the antiplatelet activity of aspirin.

Oseltamivir (Tamiflu)

  • Oseltamivir contains an ethyl ester group that is hydrolyzed by Human Carboxyl Esterase 1 (HCE1).

  • Outcome: Activation: Oseltamivir is a prodrug; the hydrolysis converts it into a carboxylic acid, which is the active species.

  • The resulting carboxylic acid has high affinity for the neuraminidase enzyme due to interactions with hydrogen bond donors in the enzyme active site.

Methylphenidate

  • Contains a methyl ester (CH3CH_3 group) that undergoes hydrolysis by carboxyl esterases.

  • Outcome: Deactivation: The parent methyl ester is the active species; the resulting carboxylic acid is inactive and highly water-soluble, allowing it to be eliminated renally.

Prasugrel and Clopidogrel (Antiplatelet Drugs)

  • Prasugrel: Hydrolyzed by esterases at an O-acetate group. A subsequent step involves hydration, though complexly mediated by Cytochrome P450.

  • Clopidogrel: Undergoes deactivation via esterase hydrolysis of its methyl ester into an inactive carboxylic acid metabolite.

  • Mechanism Note: In cases like clopidogrel, the active metabolite is formed through a different pathway (oxidation by CYP450), while the esterase pathway is a competing deactivation route.

Cocaine

  • Cocaine is subject to hydrolysis by multiple enzymes at two different sites:

    • Butyrylcholinesterase (BChE): Hydrolyzes the benzoyl ester.

    • Human Carboxyl Esterase (HCE): Hydrolyzes the methyl ester to form benzoylecgonine.

  • Outcome: Deactivation: Both hydrolysis reactions lead to the loss of cocaine's pharmacological activity.

Epoxide Hydrolase (EPHX1 and EPHX2)

  • Epoxide hydrolases (EPHX1EPHX1 and EPHX2EPHX2) catalyze the addition of water to highly strained, three-membered epoxide rings (also known as arene oxides when part of an aromatic system).

  • Substrates: Epoxides are often formed as reactive intermediates during the metabolism of alkenes or aromatic groups by Cytochrome P450.

  • Chemical Reactivity: Epoxides are highly electrophilic and reactive due to ring strain. While normal ethers are stable, the weak carbon-oxygen bonds in the strained epoxide ring allow nucleophiles to attack and open the ring.

  • Mechanism:

    • The epoxide binds to the enzyme.

    • A carboxylate group in the enzyme's catalytic triad acts as a nucleophile to open the epoxide ring, forming an ester intermediate.

    • A water molecule then hydrolyzes the ester intermediate, resulting in a 1,2-diol (a molecule with two adjacent hydroxyl groups).

  • Biological Examples:

    • Dietary Lipids: Unsaturated fatty acids like oleic acid and linoleic acid can form epoxides via CYP450 or superoxide (reactive oxygen species).

    • Detoxification: Epoxide hydrolase serves as a detoxification mechanism to prevent electrophilic epoxides from reacting with cellular proteins.

Example: Carbamazepine

  • Carbamazepine is oxidized by CYP450 to form carbamazepine epoxide.

  • Epoxide hydrolase then opens this ring to form a diol for excretion.

Therapeutic Application

  • Soluble epoxide hydrolase inhibitors are currently being developed as pharmaceutical treatments for neuropathic pain.

Evidence of Errors in Pharmacological Literature

  • The transcript highlights several errors found in published academic articles regarding chemical structures and metabolic pathways:

    • Prasugrel: An article on "Impact of Genetic Polymorphisms… on Clopidogrel and Prasugrel Response" (2013) incorrectly illustrated the structure with an inverted methyl ester (methyl ester vs. O-acetate ester).

    • Cocaine: An article on "Experimental treatments for cocaine toxicity" (2013) incorrectly attributed N-demethylation of cocaine to Butyrylcholinesterase. N-demethylation is actually performed by Cytochrome P450 (specifically CYP3A4CYP3A4), as established in earlier literature (e.g., 1994).

    • These discrepancies underscore the importance of verifying chemical structures and mechanisms against established chemistry principles.